Status:
COMPLETED
Safety Evaluation of Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients
Lead Sponsor:
Brugmann University Hospital
Conditions:
Multiparametric Magnetic Resonance Imaging
Propofol Adverse Reaction
Eligibility:
All Genders
Up to 16 years
Brief Summary
Propofol is often used for sedation in children undergoing magnetic resonance imaging. The investigators will perform a chart review of 4 month of activity (about 100 cases) and review the incidence a...
Detailed Description
Magnetic resonance imaging in children, especially under 6 years of age, is often performed under sedation. Propofol is a common drug used in this settings. In our institution, sedation is most often ...
Eligibility Criteria
Inclusion
- Pediatric patients scheduled for MRI under sedation by an anaesthesiologist
- Age \< 16 years
Exclusion
- Age \> 16 years
- Sedation performed by a non-anesthesiologist
Key Trial Info
Start Date :
July 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT04455776
Start Date
July 3 2020
End Date
July 30 2020
Last Update
August 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Universitaire des Enfants Reine Fabiola
Brussels, Belgium, 1020